Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

about

Electrophysiology and metabolism of caveolin-3-overexpressing mice.Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.Geranylgeranylacetone attenuates myocardium ischemic/reperfusion injury through HSP70 and Akt/GSK-3β/eNOS pathway.

P2860

Q37679792-4D0C075F-2C4C-4C91-81DA-EB45EFC5D61D Q38855645-E44E1B78-AABF-4F7A-94D5-939AAD95CFF4 Q42068313-A0766CFB-4F6B-4101-B890-12EE2CC368BA

P2860

Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

Item

http://www.wikidata.org/entity/Q47898318

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@en

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@nl

type

Item

label

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@en

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@nl

prefLabel

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@en

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@nl

P1476

Geranylgeranylacetone and vola ...... nt on caveolae and caveolin-3.

@en

P2093

Asuka Kasai

http://www.w3.org/2001/XMLSchema#string

Eisuke Hamaguchi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kitahata

http://www.w3.org/2001/XMLSchema#string

Katsuya Tanaka

http://www.w3.org/2001/XMLSchema#string

Noriko Kambe

http://www.w3.org/2001/XMLSchema#string

Rie Tsutsumi

http://www.w3.org/2001/XMLSchema#string

Yasuo M Tsutsumi

http://www.w3.org/2001/XMLSchema#string

Yoko Sakai

http://www.w3.org/2001/XMLSchema#string

Yousuke T Horikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning

Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling

The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK

Caveolin-3 deficiency causes muscle degeneration in mice

Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

Potential role for heat shock protein 72 in antagonizing cerebral vasospasm after rat subarachnoid hemorrhage

Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury

Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4

Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.

P304

733-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00540-014-1816-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24633659

http://www.w3.org/2001/XMLSchema#string

Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

about

P2860

P2860

Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698